Nikhilkumar Sakle | Anticancer | Research Excellence Award

Published-on by Indian Scientist

Dr. Nikhilkumar Sakle | Anticancer | Research Excellence Award

Y. B. Chavan College of Pharmacy, India

Dr. Nikhilkumar Sakle is a distinguished pharmaceutical scientist specializing in pharmacology and translational drug research. He holds advanced degrees in pharmacy and has extensive academic and teaching experience. His research focuses on anticancer therapeutics, network pharmacology, and bioactive compounds from medicinal plants. With numerous high-impact publications, patents, and funded research projects, he has earned prestigious academic awards for excellence in research and innovation. He is committed to advancing pharmaceutical sciences through impactful research, mentoring, and the development of novel therapeutic strategies for complex diseases.

Citation Metrics (Scopus)

350
250
30
20
0

Citations
330

Documents
27

h-index
11

Citations

Documents

h-index

Featured Publications

Guruvayoorappan C | Cancer | Outstanding Scientist Award

Published-on by Indian Scientist

Dr. Guruvayoorappan C | Cancer | Outstanding Scientist Award

Regional Cancer Centre, Thiruvananthapuram | India

Dr. Guruvayoorappan C is an accomplished Associate Professor at the Division of Cancer Research, Regional Cancer Centre, Thiruvananthapuram, specializing in cancer biology, immunology, and biotechnology. He holds advanced degrees in Biotechnology, Biochemistry, Botany, and Immunology, with a Ph.D. from Mahatma Gandhi University and postdoctoral research under the UGC Research Award Scheme. With over 20 years of research and 17 years of teaching experience, he has guided several Ph.D. scholars across reputed universities. His extensive contributions include 110 peer-reviewed publications, with 4096 citations, an h-index of 34, and an i10-index of 73, reflecting his impact in oncology and life sciences. His innovative research focuses on cancer immunomodulation, nanomedicine, tumor angiogenesis, and molecular mechanisms of metastasis. He has successfully led multiple government-funded research projects from DBT, ICMR, DST-SERB, and UGC, alongside patents in wound-healing nano scaffolds. Dr. Guruvayoorappan’s work has earned him prestigious honors including the UGC Research Award, DST-Early Career Research Award, ISTE-Periyar Best Teacher Award, and several fellowships from leading scientific academies. His research continues to advance understanding of tumor biology and therapeutic strategies, establishing him as a leading figure in cancer and immunological research.

Profile: Google Scholar

Featured Publications

Aggarwal, B. B., Surh, Y. J., & Shishodia, S. (Eds.). (2007). The molecular targets and therapeutic uses of curcumin in health and disease. Springer Science & Business Media.

Menon, S. S., Guruvayoorappan, C., Sakthivel, K. M., & Rasmi, R. R. (2019). Ki-67 protein as a tumour proliferation marker. Clinica Chimica Acta, 491, 39–45.

Dhanisha, S. S., Guruvayoorappan, C., Drishya, S., & Abeesh, P. (2018). Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets. Critical Reviews in Oncology/Hematology, 122, 98–122.

Rasmi, R. R., Sakthivel, K. M., & Guruvayoorappan, C. (2020). NF-κB inhibitors in treatment and prevention of lung cancer. Biomedicine & Pharmacotherapy, 130, 110569.

Kuttan, G., Hari Kumar, K. B., Guruvayoorappan, C., & Kuttan, R. (2007). Antitumor, anti-invasion, and antimetastatic effects of curcumin. In B. B. Aggarwal, Y. J. Surh, & S. Shishodia (Eds.), The molecular targets and therapeutic uses of curcumin in health and disease (pp. xx–xx). Springer Science & Business Media.